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Abstract 
The present study aims to investigate the potential adverse effects of gold nanoparticles (Au NPs) in the cortex, 
hippocampus, striatum, midbrain, cerebellum and medulla of adult male Wistar rat through the estimation of 
some oxidative stress parameters and acetylcholinesterase (AChE) activity. Rats were divided into two main 
experimental groups. Animals of the 1st and 2nd groups were intraperitoneally injected with a single dose (100 
µg/kg body wt) of ˷ 20 nm Au NPs and decapitated after 24 hours and two weeks of injection, respectively. 
Control animals were injected with saline solution and sacrificed simultaneously with the treated groups. The 
present data revealed that Au NPs induced several significant changes in the levels of GSH and NO and GST 
activities in the brain areas investigated. These changes were more prominent after 24 hours than after two 
weeks of injection and varied according to the brain region examined. However, these alterations did not induce 
lipid peroxidation except for the cerebellum and medulla after 24 hours only. In addition, Au NPs induced 
significant decreases in cortical and hippocampal AChE activities after 24 hours.  
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However, significant increases in cortical and cerebellar AChE activities were recorded after two weeks. In 
conclusion, although most of the early biochemical changes induced by Au NPs injection were ameliorated after 
two weeks, careful must be taken into consideration in utilization of gold nanoparticles in biological 
applications especially with the particle size that can penetrate the BBB.   
Keywords: nanoparticles; oxidative stress; AChE; brain; rat. 
1. Introduction  
Recently, nanoparticles (NPs) have been widely utilized in biomedical and biological applications such as 
deliver of therapeutic agents [1,2,3], photothermal therapy, bioimaging and biosensing [4,5]. However, the 
biological toxic effects of NPs cannot be ruled out [6, 7], especially, they can pass through the blood-brain 
barrier (BBB) and enter the central nervous system [8, 9,10]. 
Gold nanoparticles (Au NPs) have attracted scientific and technological attentions in biomedical applications 
due to their distinctive physical and chemical properties such as ease of synthesis, chemical stability and 
excellent optical properties [11,12,13], in addition to biocompatibility and ease of conjugation to biomolecules 
[14,15,16, 17]. Therefore, Au NPs provide an excellent tool for cancer diagnosis and treatment [18,19, 20], as 
well as transportation and delivery of therapeutic drugs [21,22,23,24]. Moreover, small size of Au NPs and their 
ability to cross the BBB are especial characteristics for delivering drugs, genes and other small molecules into 
the brain [25,26], for treatment of several neurological diseases [27]. 
Owing to the wide use of Au NPs in the biomedical applications, their cytotoxicity must be carefully 
investigated. Unfortunately, the results of these studies did not yield univocal reports. Connor and his colleagues 
[28] reported that Au NPs are taken up by human cells without cytotoxic effects. It may seems that the safety of 
Au NPs is due to the inert and nontoxic gold core in addition to their high biocompatibility [28]. However, very 
small gold-cluster may fit into the grooves of DNA-molecules [29], induce oxidative stress [30], and hence 
cause cytotoxicity. It has been found that Au NPs induced release of nitrogen oxide into serum [31], and cause 
damage to cells in vitro through oxidative stress [32]. 
The brain is more susceptible to oxidative stress due to the high utilization of oxygen, high levels of 
polyunsaturated fatty acids and the abundance of redox-active transition metal ions [33]. In addition, there are 
relatively low levels of reduced glutathione (GSH), which plays an important antioxidant role in the elimination 
of free radicals [34].  
The present study aims to investigate the early and delayed potential adverse effects of intraperitoneal injection 
(i.p.) of ˷ 20 nm Au NPs in different rat brain regions through estimation of some oxidative stress parameters 
and acetylcholinesterase (AChE) activity.  
2. Materials and Methods 
2.1. Experimental animal 
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The experimental animals used in the present study were adult male Wistar rats weighing 150-200 g. They were 
given standard laboratory diet and water ad libitum. The animals were maintained under fixed appropriate 
conditions of housing and handling. Experimental protocols and procedures used in this study were approved by 
the Cairo University, Faculty of Science Institutional Animal Care and Use Committee (IACUC) (Egypt), 
(CUFS/F/06/13). All the experimental procedures were carried out in accordance with international guidelines 
for the care and use of laboratory animals. 
2.2. Chemicals 
Stabilized suspension of Au NPs (˷20 nm diameter) in 0.1 mM PBS was purchased from Sigma-Aldrich Co. 
Thiobarbituric acid (TBA) and reduced glutathione were purchased from Sigma Aldrich, Germany. 1-Chloro- 2, 
4-dinitrobenzene (CDNB) was purchased from Sigma Aldrich, St. Louis, USA. Trichloroacetic acid (TCA) was 
obtained from SDFCL (SD Fine-Chem Limited), Egypt. Potassium phosphate buffer pH 7.4 (50 mM/L, Triton · 
0.1%, EDTA 0.5 ml), potassium phosphate buffer pH 6.5 (100 mM/ L) were obtained from Bio Diagnostic Co., 
Giza, Egypt. All other reagents were analytical grade reagents purchased from Sigma Chemical Co. (St. Louis, 
MO, USA).  
2.3. Characterization of Au NPs 
2.3.1. Dynamic light scattering (DLS) 
By dynamic light scattering (DLS) technique using the Malvern Zeta Sizer model 1000HSa, the hydrodynamic 
diameter of gold nanoparticles was determined. The instrument calculates the average size of the nanoparticles 
depending on the measured time-dependent fluctuations of the light scattered by nanoparticles. 
2.3.2. Zeta potential analysis  
 Using Zetasizer Nano ZS90 (Malvern Instruments, UK), the zeta potentials and electrophoretic mobilities of 
gold nanoparticles were measured. The gold nanoparticles solution was placed in the sample holder and a laser 
beam at 633 nm was localized on the sample. Scattered light was detected by a photomultiplier tube. 
2.3.3. UV- visible spectroscopy  
Using a double beam UV–vis spectrophotometer (Uv-160A, Shimadzu, Japan)  in the range of 400–800 nm, 
with a resolution of 1 nm using a 1 nm slit width and a 0.3 nm/s scan rate, the absorption spectrum of gold 
nanoparticles was recorded. 
2.3.4. Transmission electron microscope (TEM) 
Gold nanoparticles were analyzed by negative stain electron microscopy using (JEOL JEM.1400 Electron 
microscope). In the center of carbon coated 300-mesh copper grids, 1-2 μl drop of the solution was placed in          
a formvar support grid and allowed to air dry. The sample was visualized using TEM microscope operated at 
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200kV and the image was obtained.   
2.4. Experimental design 
Adult male Wistar rats were divided into two main experimental groups. Each main group was subdivided into 
two subgroups (control group and treated group). The treated animals of both 1st and 2nd groups were 
intraperitoneally injected with a single dose (100 µg/kg body wt) of ˷ 20 nm Au NPs. Control animals were 
injected with saline solution. Animals of the 1st experimental group were suddenly decapitated after 24 hours of 
injection. Meanwhile, animals of the 2nd group were suddenly decapitated after two weeks of injection. Control 
animals were sacrificed simultaneously with the treated groups.  
2.5. Handling of tissue samples 
The animals were suddenly decapitated and the brain of each animal was quickly removed and rapidly 
transferred to an ice-cold Petri dish. Each brain was dissected to obtain the cortex, hippocampus, striatum, 
midbrain, cerebellum and medulla. Each brain region was divided into two equal halves, weighed and kept at                      
–20ºC until analyzed. The right half of each brain region was homogenized in 5% w/v 20 mM phosphate buffer, 
pH 7.4, centrifuged and the supernatant was utilized for the analysis of the levels of malondialdehyde (MDA), 
reduced glutathione (GSH) and nitric oxide (NO) and activities of glutathione-s-transferase (GST) and 
acetylcholinesterase (AChE).  
2.5.1. Determination of lipid peroxidation 
Lipid peroxidation was measured by determining the level of malondialdehyde (MDA) as indicated by the 
thiobarbituric reactive species (TBARS) in the tissues according to the method of Ruiz-Larrea and his 
colleagues [35]. Thiobarbituric acid  react with the thiobarbituric acid reactive substances to produce a pink 
colored complex whose absorbance is read at 532 nm in   a Helios Alpha Thermo spectronic (UVA 111615, 
England). 
 2.5.2. Determination of reduced glutathione level  
Reduced glutathione (GSH) was estimated according to Ellman's [36]. Ellman´s reagent is reduced by –SH 
groups of GSH producing 2-nitro-s-mercaptobenzoic acid. The intense yellow color of nitromercaptobenzoic 
acid anion has an absorbance is measured spectrophotometrically at 412 nm.  
2.5.3. Determination of nitric oxide level  
According to the method of Moshage and his colleagues [37], nitric oxide (NO) level was estimated as nitrite 
using Griess reagent. Nitrite is converted to a deep purple azo compound after the addition of Griess reagent. 
The absorbance is measured spectrophotometrically at 450 nm. 
2.5.4. Determination of glutathione-s-transferase activity  
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Glutathione-S-transferase (GST) was determined according to the method of Habig and his colleagues [38]. It 
measures the conjugation of GSH with 1-chloro-2,4-dinitrobenzene. This conjugation is accompanied by an 
increase in the absorbance at 340 nm, the GST activity being directly proportional to the rate of absorbance 
increase. 
2.5.5. Determination of acetylcholinesterase (AChE) activity 
The procedure used for the determination of AChE activity was a modification of the method of Ellman and his 
colleagues [39] as described by Gorun and his colleagues [40]. It measures the thiocholine produced as 
acetylthiocholine is hydrolyzed. Thiocholine is reacted with the -SH reagent 5,5'-dithiobis-(2-nitrobenzoic acid) 
(DTNB), which is reduced to thionitrobenzoic acid producing a yellow colored anion whose absorption was 
read immediately at 412 nm. 
2.6. Statistical analysis 
The data were expressed as means ± standard error of the mean (S.E.M.) Data were analyzed by Student's t- test. 
The difference between means was significant at p< 0.05. 
3. Results 
3.1. Dynamic light scattering (DLS) 
Using DLS, the measured mean diameter of gold nanoparticles was found to be 20 nm ± 1 nm. 
3.2. Zeta potential analysis  
The mean of the zeta potential for gold nanoparticles was found to be -0.09 mV. 
 
Figure 1: Visible absorption spectrum for gold nanoparticles 
3.3. UV- visible spectroscopy  
Gold nanoparticles showed a specific absorption peak at 520 nm as seen in Figure 1. 
3.4. Transmission electron microscope (TEM) 
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As depicted from Figure 2, using TEM, gold nanoparticles showed uniform spheres of diameter of about 20 nm. 
 
Figure 2: Gold nanoparticles ultrastructure 
3.5. Biochemical parameters  
Tables (1-5) represented the effect of single i.p. injection (100 µg/kg body wt) of ˷ 20 nm Au NPs on some 
oxidative stress parameters and AChE activity in different brain areas of adult male albino rats after 24 hours 
(early effect) and two weeks (late effect) of injection. 
Table 1: Effect of i.p. injection of 20 nm Au NPs on MDA level (nmol/g tissue) in different brain areas of adult 
male Wistar rat 
 
Brain area 
After 24 hours After 2 weeks 
Control Treated T-test Control Treated T-test 
Cortex 4.36 ± 0.13 
 (7) 
4.38 ± 0.30 
 (7) 
n.s. 3.61 ± 0.35 
(6) 
3.90 ± 0.27 
(6) 
n.s. 
Hippocampus 18.61 ± 1.56 
(5) 
18.56 ± 0.99 
(5) 
n.s. 13.64 ± 0.90 
(5) 
15.17 ± 1.50 
(5) 
n.s. 
Striatum 14.81 ± 1.26 
(6) 
14.52 ± 0.87 
(6) 
n.s. 16.84 ± 2.41 
(5) 
24.13 ± 2.75 
(5) 
n.s. 
Midbrain 10.59 ± 0.42 
(5) 
9.02 ± 0.63 
(5) 
n.s. 7.42 ± 0.46 
(7) 
6.60 ± 0.55 
(7) 
n.s. 
Cerebellum 5.47 ± 0.47 
(5) 
8.64 ± 0.28 
(5) 
* 7.39 ± 0.45 
(6) 
7.73 ± 0.57 
(6) 
n.s. 
Medulla 6.77 ± 0.25 
(7) 
10.30 ± 1.11 
(5) 
* 6.34 ± 0.31 
(7) 
6.31 ± 0.19 
(6) 
n.s. 
Values represent the mean ± S. E. M. with the number of animals between parentheses. 
n.s.: non-significant.  *: p < 0.05 significant.   
As shown in Table (1), MDA levels were non significantly changed in the cortex, hippocampus, striatum and 
midbrain either after 24 hours or two weeks of Au NPs injection. However, significant increases in MDA levels 
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were observed in the cerebellum and medulla after 24 hours and these increases returned to the normal like 
values after two weeks of injection. GSH content recorded significant decreases  in the hippocampus and 
striatum after 24 h of injection, on the other hand, the hippocampal and midbrain GSH content recorded 
significant increases after two weeks of Au NPs injection. However, non significant changes were recorded in 
the other brain areas (table 2).  Table (3) revealed that NO levels showed significant increases in the cortex and 
medulla while significant decreases were recorded in the hippocampus and midbrain after 24 h of injection.  
However, the early significant decrease in midbrain NO level was persisted till the two weeks of Au NPs 
injection and was accompanied by  a significant increase in its level in the cerebellum.  Regarding GST activity, 
Table (4) indicated significant decreases in the cortical, striatal and midbrain GST activities after 24 hours. A 
significant decrease in hippocampal GST activity was recorded after two weeks of Au NPs injection. Au NPs 
injection induced significant decreases in cortical and hippocampal AChE activities after 24 hours (Table 5). 
However, late (after twoweeks) significant increases in cortical and cerebellar AChE activities were recorded.  
 
Table 2: Effect of i.p. injection of 20 nm Au NPs on GSH level (mg/g tissue) in different brain areas of adult 
male Wistar rat 
 
Brain area 
After 24 hours After 2 weeks 
Control Treated T-test Control Treated T-test 
Cortex 4.56 ± 0.13 
(7) 
4.85 ± 0.12 
(8) 
n.s. 4.31 ± 0.11 
(5) 
4.68 ± 0.12 
(8) 
n.s. 
Hippocampus 34.50 ± 0.58 
(5) 
25.33 ± 0.72 
(6) 
* 24.09 ± 0.55 
(6) 
27.19 ± 0.69 
(7) 
* 
Striatum 33.14 ± 0.79 
(5) 
25.56 ± 1.54 
(5) 
* 26.85 ± 0.88 
(6) 
28.12 ± 0.77 
(6) 
n.s. 
Midbrain 21.12 ± 1.13 
(6) 
19.87 ± 0.42 
(6) 
n.s. 18.75 ± 1.17 
(7) 
24.17 ± 0.66 
(6) 
* 
Cerebellum 11.49 ± 0.31 
(7) 
10.83 ± 0.41 
(7) 
n.s. 7.53 ± 0.45 
(7) 
8.30 ± 0.33 
(7) 
n.s. 
Medulla 11.14 ± 0.45 
(7) 
11.67 ± 0.82 
(6) 
n.s. 6.43 ± 0.33 
(7) 
7.49 ± 0.35 
(6) 
n.s. 
Values represent the mean ± S. E. M. with the number of animals between parentheses. n.s.: non-
significant.   *: p < 0.05 significant  
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Table 3: Effect of i.p. injection of 20 nm Au NPs on NO level (µ mole/g tissue) in different brain areas of adult 
male Wistar rat 
 
Brain area 
After 24 hours After 2 weeks 
Control Treated T-test Control Treated T-test 
Cortex 0.23 ± 0.01 
(7) 
0.30 ± 0.02 
(6) 
* 0.50 ± 0.08 
(6) 
0.69 ± 0.05 
(6) 
n.s. 
Hippocampus 1.12 ± 0.10 
(8) 
0.78 ± 0.07 
(7) 
* 0.56 ± 0.04 
(5) 
0.68 ± 0.09 
(5) 
n.s. 
Striatum 1.65 ± 0.14 
(8) 
1.70 ± 0.11 
(8) 
n.s. 2.28 ± 0.33 
(7) 
3.47 ± 0.56 
(7) 
n.s. 
Midbrain 1.31 ± 0.06 
(6) 
1.09 ± 0.06 
(6) 
* 1.34 ± 0.12 
(6) 
0.81 ± 0.09 
(6) 
* 
Cerebellum 1.26 ± 0.06 
(7) 
1.20 ± 0.04 
(7) 
n.s. 1.54 ± 0.08 
(7) 
1.96 ± 0.07 
(7) 
* 
Medulla 1.82 ± 0.13 
(6) 
3.19 ± 0.18 
(6) 
* 1.12 ± 0.06 
(8) 
1.32 ± 0.07 
(5) 
n.s. 
Values represent the mean ± S. E. M. with the number of animals between parentheses. 
n.s.: non-significant.   *: p < 0.05 significant.          
Table 4: Effect of i.p. injection of 20 nm Au NPs on GST (U/g tissue) activity in different brain areas of adult 
male Wistar rat 
 
Brain area 
After 24 hours After 2 weeks 
Control Treated T-test Control Treated T-test 
Cortex 0.28 ± 0.01 
(8) 
0.14 ± 0.01 
(7) 
* 0.42 ± 0.03 
(7) 
0.44 ± 0.02 
(7) 
n.s. 
Hippocampus 1.52 ± 0.15 
(6) 
1.31 ± 0.09 
(8) 
n.s. 1.72 ± 0.06 
(6) 
1.33 ± 0.06 
(8) 
* 
Striatum 1.61 ± 0.21 
(5) 
0.67 ± 0.03 
(5) 
* 1.35 ± 0.08 
(6) 
1.33 ± 0.05 
(7) 
n.s. 
Midbrain 1.23 ± 0.08 
(7) 
0.96 ± 0.10 
(6) 
* 1.29 ± 0.12 
(5) 
1.09 ± 0.04 
(8) 
n.s. 
Cerebellum 0.70 ± 0.04 
(8) 
0.60 ± 0.02 
(6) 
n.s. 0.48 ± 0.04 
(7) 
0.56 ± 0.03 
(8) 
n.s. 
Medulla 0.64 ± 0.05 
(7) 
0.67 ± 0.04 
(7) 
n.s. 0.54 ± 0.04 
(8) 
0.63 ± 0.03 
(6) 
n.s. 
Values represent the mean ± S. E. M. with the number of animals between parentheses. 
n.s.: non-significant.  *: p < 0.05 significant.        
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Table 5: Effect of i.p. injection of 20 nm Au NPs on AChE activity (µmol SH/g/min) in different brain areas of 
adult male Wistar rat 
 
Brain area 
After 24 hours After 2 weeks 
Control Treated T-test Control Treated T-test 
Cortex 11.49 ± 0.44 
(7) 
9.16 ± 0.40 
(7) 
* 15.98 ± 0.67 
(6) 
19.90 ± 0.37 
(5) 
* 
Hippocampus 24.60 ± 2.28 
(5) 
18.51 ± 0.76 
(5) 
* 22.51 ± 1.33 
(7) 
24.12 ± 0.53 
(6) 
n.s. 
Striatum 50.12 ± 2.63 
(5) 
42.16 ± 3.39 
(5) 
n.s. 46.72 ± 2.38 
(6) 
43.83 ± 2.09 
(6) 
n.s. 
Midbrain 27.84 ± 0.98 
(5) 
28.44 ± 0.70 
(5) 
n.s. 27.95 ± 1.29 
(5) 
25.73 ± 0.85 
(6) 
n.s. 
Cerebellum 18.05 ± 0.56 
(6) 
19.98 ± 1.22 
(5) 
n.s. 18.28 ± 0.73 
(6) 
21.47 ± 0.70 
(7) 
* 
Medulla 28.44 ± 1.40 
(5) 
30.08 ± 1.52 
(5) 
n.s. 25.95 ± 1.14 
(6) 
28.36 ± 0.72 
(8) 
n.s. 
Values represent the mean ± S. E. M. with the number of animals between parentheses. 
n.s.: non-significant.   *: p < 0.05 significant.           
4. Discussion 
The present study investigated the potential neurotoxicity of gold nanoparticles in different brain areas after 24 
hours (early effect) and two weeks (late effect) of a single i.p. injection of ˷ 20 nm Au NPs. Kim and his 
colleagues [41] investigated the possibility of 20 nm Au NPs to penetrate the mouse blood-retinal barrier and 
indicated the presence of 20 nm Au NPs in all retinal layers especially neurons (70%). In addition, Studies of 
Sonavane and his colleagues [42] have demonstrated that 15–50-nm AuNPs can penetrate the BBB, causing 
their accumulation in the brain. Furthermore, Cardoso and his colleagues [43] found that acute and chronic i.p. 
injection of 10 and 30 nm Au NPs induced DNA damage in the rat cerebral cortex. 
The present data revealed that ˷ 20 nm Au NPs induced several significant changes in the levels of GSH and NO 
and GST activities in the brain areas under investigation. These changes were more prominent after 24 hours 
than after two weeks of injection and varied according to the brain region examined. However, these alterations 
did not induce lipid peroxidation except for the cerebellum and medulla which showed an early increase in 
MDA level then it returned to normal-like value after two weeks.  
Therefore, the present data confirmed the ability of ˷ 20 nm Au NPs to penetrate the BBB and exert several 
alterations in the brain areas under investigation. In addition, the present findings supported the previous study 
of Li and his colleagues [32] as they indicated that Au NPs exert oxidative stress, which damages cells in vitro. 
Recently, Siddiqi and his colleagues [44] found that i.p injection of 20 nm Au NPs for 3 days induced oxidative 
International Journal of Sciences: Basic and Applied Research (IJSBAR)(2016) Volume 30, No  5, pp 114-129 
123 
 
stress which was evident by increase in lipid peroxidation accompanied by deterioration of the antioxidant 
enzyme, glutathione peroxidase in the rat brain. Therefore, the present study boosts the results of Siddiqi and his 
colleagues [44] through investigating the oxidative stress parameters in each brain area of adult male rat. 
Data of the present study recorded early significant decreases in hippocampal and striatal GSH levels. These 
decreases were accompanied by significant decreases in NO level and GST activity in the hippocampus and 
striatum, respectively. In addition, cortical and midbrain GST activities showed early significant decreases. 
Shrivastava and his colleagues [45] found that oral treatment with Au NPs for 14 days increased ROS formation 
and decreased GSH:GSSG ratio in the mouse brain. However, their results revealed increase in the GST activity 
on the contrary of the present data. This controversy may be due to the difference in experimental animal, study 
protocol and measurement in whole brain rather than different brain regions. 
GSH plays a major role as an antioxidant protecting cells against oxidative stress and xenobiotics, as well as 
preserving the thiol redox state especially in the CNS [46]. GSH, non-enzymatically, scavenges ROS and, 
enzymatically, acts as an electron donor in the reduction of peroxides catalyzed by glutathione peroxidase 
producing glutathione disulfide (GSSG) which is reduced by glutathione reductase back to GSH [47]. 
Glutathione-S-transferases (GSTs) are a family of enzymes that catalyze the addition of GSH to endogenous and 
xenobiotic substances which have electrophilic functional groups [48].  
Therefore, it could be suggested that the present decrease in GSH level may be due to its consumption in 
scavenging the rapidly liberated free radicals especially NO in the hippocampus as GSH reacts non- 
enzymatically with NO [49]. In addition, the decrease in GST activity may be due to the decrease in its 
substrate, GSH as in the striatum or its exhaustion as a result of catalyzing detoxification reactions as in the 
cortex and midbrain. Fortunately, these early recorded changes in GSH levels and GST activities exerted 
successful role in counteracting the liberated free radicals which is evident from non significant changes 
recorded in MDA levels in the cortex, hippocampus, striatum and midbrain.  
In contrast, data of the present investigation recorded early significant increase in the cerebellar MDA level in 
addition to significant increases in both MDA and NO levels in the medulla after 24 hours of Au NPs. These 
results indicate the variability of brain regions in their tolerance against the free radicals and therefore, may raise 
concerns about the safety of Au NPs in medical applications. 
 In vitro study of Jung and his colleagues [50] demonstrated that Au NPs caused hippocampal CA1 neurons to 
be more excitable in terms of generating more action potentials which might lead to disruptions in neuronal 
functions and hyperexcitability in pathological conditions such as seizure. In addition, it has been suggested that 
brain functions may be affected by accumulation of inhaled AuNPs in the hippocampus [51]. 
Acetylcholinesterase (AChE) has a substantial role in cholinergic neurotransmission because it causes the 
hydrolysis of acetylcholine released into the synapse [52]. Results of the present study revealed that a single i.p. 
injection of Au NPs induced early (after 24 hours) significant decreases in AChE activities in the cortex and 
hippocampus.  
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The hippocampus has been a focus of attention in research of temporal lobe epilepsy as it contains several 
neuronal circuits associated with seizure onset and because it develops, in the time course of the disease, a 
severe loss of pyramidal cells in CA1, CA3 and the dentate gyrus [53]. Epilepsy has been related to release or 
overproduction of acetylcholine in the brain, due to a neuronal hyperactivity and/or an excitotoxicity, that might 
induce a neuronal damage during pilocarpine-induced seizure and status epilepticus [54,55]. 
Therefore, the present decrease in both cortical and hippocampal  AChE activities may reflect an increase in 
cholinergic neurotransmission in these brain regions which could underlie the reported hippocampal hyper- 
excitability under the effect of Au NPs [50]. Hence, caution must be taken when using Au NPs in epileptic 
patients or people susceptible to epilepsy. 
On the other hand, the study of Chen and his colleagues [56] demonstrated that a single i.p. injection of 17 nm 
Au NPs decreased the latency time, which was comparable to the effect of scopolamine treatment, while 37 nm 
Au NPs showed no significant effect. The authors concluded that the ability of Au NPs to impair cognition in 
mice was size-dependent and related to the ability of the particles to attack the hippocampus. It has been 
evidenced that high brain acetylcholine levels are associated with cognitive dysfunction [57]. In addition, 
elevated hippocampal nitrite level was found to be accompanied by learning of spatial task in rats [58]. 
Moreover, NO - cyclic guanosine mono- phosphate (NO-cGMP) pathway has been involved in the induction of 
hippocampal long-term potentiation (LTP) and long-term depression (LTD) which are known to be the 
predominant mechanisms of learning and memory processes [59].  
Therefore, the present decrease in the hippocampal AChE after 24 hours of i.p. Au NPs injection may mediate 
increased acetylcholine level which could interpret the cognition impairment induced by Au NPs [56], 
especially in the presence of concomitant decrease in hippocampal NO level.  
The present study extended to examine the delayed effect of i.p. injection of Au NPs on the oxidative status as 
well as cholinergic activity of the brain regions under investigation. Surprisingly, data revealed that most of the 
early changes in oxidative stress parameters has been ameliorated after two weeks of Au NPs injection even the 
increased levels of cerebellar and medullary MDA, observed in the early stage, were returned to the normal  
levels after two weeks.  
Furthermore, the early significant decrease in the cortical AChE activity was reversed to significant increase 
after two weeks of Au NPs injection. This could be an attempt of the brain to relief the state of the early 
increased cholinergic activity as a result of early inhibited AChE activity observed after 24 hours of Au NPs 
injection.   
5. Conclusion 
Although most of the early biochemical changes induced by a single injection of Au NPs were ameliorated after 
two weeks, further studies are recommended to investigate the effect of repeated doses of Au NPs. However, 
care must be taken into consideration when utilizing gold nanoparticles in biological applications especially 
with the particle size that can penetrate the BBB.    
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